Skip to content

High amylase resistant starch to decrease stool output in people with short bowel syndrome

High amylase resistant starch to decrease stool output in people with short bowel syndrome

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000220268
Enrollment
5
Registered
2018-02-12
Start date
2013-10-14
Completion date
2016-01-06
Last updated
2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Short bowel syndrome is defined as not having enough bowel to be able to absorb enough nutrition from food to maintain body weight. Short bowel syndrome causes diarrhoea and large fluid losses as a result of not being able to absorb what has been eaten / drunk. This means many people with short bowel syndrome rely on intravenous nutrition and or hydration. Recent studies have shown that adding resistant starch (a form of carbohydrate found in food) to rehydration solutions that you drink can reduce diarrhoea in cases from a number of different causes. There are no studies investigating the use of resistant starch to reduce stool output in participants with short bowel syndrome. It appears as though resistant starch works when it is fermented by the bacteria that live in the large bowel. A by-product of this fermentation are short chain fatty acids (SCFA). SCFA’s increase the large bowel’s ability to absorb water and salts leading to less diarrhoea and fluid loss. The aim of this study is to determine if adding resistant starch to a rehydration solution that you drink can reduce diarrhoea and fluid loss in people with short bowel syndrome. If it is effective it may have the potential to reduce the amount of IV fluids needed for some people. Resistant starch is present naturally in some foods and is approved as a food additive to increase the dietary fibre content. This trial is aimed to determine if resistant starch can decrease diarrhea in people with short bowel syndrome. It is a 2 week trial. Participants will complete both the control and the intervention. In the treatment group you will be provided with 50g of starch powder to add to St Marks’s oral rehydration solution. You will be asked to drink 4 glasses of St Mark’s solution daily, each containing a tablespoon of the powder. In the control group participants will be asked to drink 4 glasses of St Mark’s solution daily without any additions. During each study period participants will otherwise eat and drink as normal and asked not to make any dietary changes during the study periods. During the trial period participants will be asked to record the number of bowel actions they have each day and on days 2, 4 and 7 you will be asked to weigh each bowel action with scales that will be provided to record a daily total. Results will be compared between groups

Interventions

Addition of 50g per day of high amylase resistant starch to usual diet to determine changes in stool output. Participants will act as their own control as this is a crossover trial. Each participant will complete the control and intervention arm of the trial. Each arm of the trial will last for 1 week, as week one is a control (usual diet and fluids) period no wash out is required. Participants will self administer the resistant starch by adding 1tbl per glass of St marks solution 4 times daily

Addition of 50g per day of high amylase resistant starch to usual diet to determine changes in stool output. Participants will act as their own control as this is a crossover trial. Each participant will complete the control and intervention arm of the trial. Each arm of the trial will last for 1 week, as week one is a control (usual diet and fluids) period no wash out is required. Participants will self administer the resistant starch by adding 1tbl per glass of St marks solution 4 times daily. Resistant starch is a soluble tasteless powder which is undetectable in food and fluids.

Sponsors

Austin Health
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults with short bowel syndrome and colon in continuity

Exclusion criteria

Fluid restriction Absence of colon Inability to take food / fluids orally

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026